Search Results

There are 23694 results for: content related to: Is Response to OROS-Methylphenidate Treatment Moderated by Treatment with Antidepressants or Psychiatric Comorbidity? A Secondary Analysis from a Large Randomized Double Blind Study of Adults with ADHD

  1. Stimulants

    Psychiatry, Third Edition

    Natalya Paykina, Laurence L. Greenhill, Kelly N. Fahl, J. Craig Nelson, Pages: 2264–2293, 2008

    Published Online : 8 AUG 2008, DOI: 10.1002/9780470515167.ch106

  2. You have free access to this content
    Naturalistic exploration of the effect of osmotic release oral system-methylphenidate on remission rate and functional improvement in Taiwanese children with attention-deficit–hyperactivity disorder

    Psychiatry and Clinical Neurosciences

    Volume 66, Issue 1, February 2012, Pages: 53–63, Ruu-Fen Tzang, Ya-Ching Wang, Chin-Bin Yeh, Cheng-Dien Hsu, Hsin-Yi Liang, Pin-Chen Yang, Hung-Jen Liu, Yu-Shu Huang, Helen Cheng, Ya-Chen Hsu, Shen-Ing Liu, Chia-Ho Pan, Ya-Fen Huang, Chi-Fen Huang, Yu-Yu Wu, Yu-Hsin Huang, Hui-Ching Liu and Hsueh-Ling Chang

    Version of Record online : 18 JAN 2012, DOI: 10.1111/j.1440-1819.2011.02289.x

  3. You have free access to this content
    Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)

    Intervention Review

    The Cochrane Library

    Ole Jakob Storebø, Erica Ramstad, Helle B. Krogh, Trine Danvad Nilausen, Maria Skoog, Mathilde Holmskov, Susanne Rosendal, Camilla Groth, Frederik L Magnusson, Carlos R Moreira-Maia, Donna Gillies, Kirsten Buch Rasmussen, Dorothy Gauci, Morris Zwi, Richard Kirubakaran, Bente Forsbøl, Erik Simonsen and Christian Gluud

    Published Online : 25 NOV 2015, DOI: 10.1002/14651858.CD009885.pub2

  4. Advances in the Pharmacotherapy of Attention-Deficit-Hyperactivity Disorder: Focus on Methylphenidate Formulations

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 23, Issue 10, October 2003, Pages: 1281–1299, Dr. John S. Markowitz, Dr. Arthur B. Straughn and Dr. Kennerly S. Patrick

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.23.12.1281.32697

  5. ADHD Clinical Trials

    Clinical Trials in Psychopharmacology: A Better Brain, Second Edition

    Marc Hertzman, Lawrence Adler, Pages: 251–272, 2010

    Published Online : 25 JAN 2010, DOI: 10.1002/9780470749180.ch13

  6. Attention-Deficit-Hyperactivity Disorder: An Update

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 6, June 2009, Pages: 656–679, Dr. Julie A. Dopheide and Dr. Steven R. Pliszka

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.29.6.656

  7. Toward personalized smoking-cessation treatment: Using a predictive modeling approach to guide decisions regarding stimulant medication treatment of attention-deficit/hyperactivity disorder (ADHD) in smokers

    The American Journal on Addictions

    Volume 24, Issue 4, June 2015, Pages: 348–356, Sean X. Luo, Lirio S. Covey, Mei-Chen Hu, Frances R. Levin, Edward V. Nunes and Theresa M. Winhusen

    Version of Record online : 6 FEB 2015, DOI: 10.1111/ajad.12193

  8. You have free access to this content
    Brain Biochemical Effects of Methylphenidate Treatment Using Proton Magnetic Spectroscopy in Youth with Attention-Deficit Hyperactivity Disorder: A Controlled Pilot Study

    CNS Neuroscience & Therapeutics

    Volume 18, Issue 1, January 2012, Pages: 34–40, Paul Hammerness, Joseph Biederman, Carter Petty, Aude Henin and Constance M. Moore

    Version of Record online : 8 DEC 2010, DOI: 10.1111/j.1755-5949.2010.00226.x

  9. You have free access to this content
    Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction

    British Journal of Clinical Pharmacology

    Volume 77, Issue 2, February 2014, Pages: 337–356, José Pérez de los Cobos, Núria Siñol, Víctor Pérez and Joan Trujols

    Version of Record online : 22 JAN 2014, DOI: 10.1111/bcp.12045

  10. The impact of individual and methodological factors in the variability of response to methylphenidate in ADHD pharmacogenetic studies from four different continents

    American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

    Volume 147B, Issue 8, 5 December 2008, Pages: 1419–1424, Guilherme Polanczyk, Stephen V. Faraone, Claiton H.D. Bau, Marcelo M. Victor, Katja Becker, Reta Pelz, Jan K. Buitelaar, Barbara Franke, Sandra Kooij, Emma van der Meulen, Keun-Ah Cheon, Eric Mick, Diane Purper-Ouakil, Philip Gorwood, Mark A. Stein, Edwin H. Cook Jr. and Luis Augusto Rohde

    Version of Record online : 18 SEP 2008, DOI: 10.1002/ajmg.b.30855

  11. You have full text access to this OnlineOpen article
    Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial

    Addiction

    Volume 109, Issue 3, March 2014, Pages: 440–449, Maija Konstenius, Nitya Jayaram-Lindström, Joar Guterstam, Olof Beck, Björn Philips and Johan Franck

    Version of Record online : 1 DEC 2013, DOI: 10.1111/add.12369

    Corrected by:

    CORRIGENDUM: Corrigendum

    Vol. 109, Issue 9, 1571–1572, Version of Record online: 8 AUG 2014

  12. Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults

    Intervention Review

    The Cochrane Library

    Xavier Castells, Josep Antoni Ramos-Quiroga, Rosa Bosch, Mariana Nogueira and Miguel Casas

    Published Online : 15 JUN 2011, DOI: 10.1002/14651858.CD007813.pub2

  13. You have free access to this content
    Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes

    Psychiatry and Clinical Neurosciences

    Volume 63, Issue 2, April 2009, Pages: 167–175, Wen-Jiun Chou, Miao-Chun Chou, Ruu-Fen Tzang, Ya-Chen Hsu, Susan Shur-Fen Gau, Shin-Jaw Chen, Yu-Yu Wu, Ya-Fen Huang, Hsin-Yi Liang and Helen Cheng

    Version of Record online : 20 MAR 2009, DOI: 10.1111/j.1440-1819.2009.01937.x

  14. You have free access to this content
    Research Poster Abstracts

    Value in Health

    Volume 11, Issue 6, November 2008, Pages: A362–A659,

    Version of Record online : 14 OCT 2008, DOI: 10.1111/j.1524-4733.2008.00453_2.x

  15. You have free access to this content
    ADHD pharmacogenetics across the life cycle: New findings and perspectives

    American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

    Volume 165, Issue 4, June 2014, Pages: 263–282, Estela Maria Bruxel, Glaucia Chiyoko Akutagava-Martins, Angelica Salatino-Oliveira, Verônica Contini, Christian Kieling, Mara Helena Hutz and Luis Augusto Rohde

    Version of Record online : 8 MAY 2014, DOI: 10.1002/ajmg.b.32240

  16. Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1)

    American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

    Volume 147B, Issue 2, 5 March 2008, Pages: 201–208, J. Sandra Kooij, A. Marije Boonstra, Sita H. Vermeulen, Angelien G. Heister, Huibert Burger, Jan K. Buitelaar and Barbara Franke

    Version of Record online : 22 OCT 2007, DOI: 10.1002/ajmg.b.30586

  17. Dose-Proportional and Stereospecific Pharmacokinetics of Methylphenidate Delivered Using an Osmotic, Controlled-Release Oral Delivery System

    The Journal of Clinical Pharmacology

    Volume 40, Issue 10, October 2000, Pages: 1141–1149, Dr. Nishit B. Modi, Dr. Bei Wang, Dr. Robert J. Noveck and Dr. Suneel K. Gupta

    Version of Record online : 8 MAR 2013, DOI: 10.1177/009127000004001008

  18. You have free access to this content
    Research Podium Abstracts

    Value in Health

    Volume 11, Issue 6, November 2008, Pages: A335–A362,

    Version of Record online : 14 OCT 2008, DOI: 10.1111/j.1524-4733.2008.00453_1.x

  19. You have free access to this content
    Effect of osmotic-release oral system methylphenidate on different domains of attention and executive functioning in children with attention-deficit–hyperactivity disorder

    Developmental Medicine & Child Neurology

    Volume 53, Issue 9, September 2011, Pages: 843–849, NATHAN J BLUM, ABBAS F JAWAD, ANGELA T CLARKE and THOMAS J POWER

    Version of Record online : 18 MAY 2011, DOI: 10.1111/j.1469-8749.2011.03944.x

  20. Use of varenicline versus bupropion and risk of psychiatric adverse events

    Addiction

    Volume 108, Issue 7, July 2013, Pages: 1336–1343, Björn Pasternak, Henrik Svanström and Anders Hviid

    Version of Record online : 4 APR 2013, DOI: 10.1111/add.12165